Whistleblowing scheme of the Danish Medicines Agency from 1 January 2025 to 31 December 2025 (system of openness)

The Danish Whistleblower Act obliges authorities that are subject to the rules of the Access to Public Administration Files Act to publish, at least once a year, information on the activities they have carried out under the Danish Whistleblower Act – a so-called system of openness (offentlighedsordning).

The system serves to ensure that the public has access to information on the authority’s general whistleblowing activity in the past year.

In compliance with the Danish Whistleblower Act, the whistleblower unit of the Danish Medicines Agency hereby reports that the agency received no reports under its whistleblowing scheme during the period from 1 January 2025 to 31 December 2025.

Find out more about our whistleblowing scheme here.